NF1 and neurofibromatosis type 1: Most important, from a clinical point of view, these molecular and structural beneficial effects were followed by improvements in callus mechanical properties, which thus confirm that targeting the specific defects caused by loss of Nf1 function could be an efficient strategy to improve bone healing in NF1 patients.